Health Canada and U.S. Food and Drug Administration’s joint eSTAR pilot has reached its total of 9 participants. Requests to participate in the pilot are no longer being accepted.
eSTAR is an interactive PDF form that guides applicants through the process of preparing a comprehensive medical device submission. The template contains the following features:
eSTAR is free and available for voluntary use to all medical device submitters for 510(k)s and De Novos submitted to CDRH. The eSTAR is not currently for use with combination products. For more information on the use of eSTAR for premarket submissions, please visit the webpage Voluntary eSTAR Program.
The FDA and Health Canada are conducting a joint pilot to test the use of a single eSTAR submitted to both the FDA and Health Canada. The feasibility of using eSTAR will be determined by the outcome of a pilot with 9 participants. Selected participants will use the non-In Vitro Diagnostic eSTAR, which follows the structure of the IMDRF Non-In Vitro Diagnostic Device Market Authorization Table of Contents (nIVD MA ToC). Request for participation in the pilot is now closed.
To be eligible to participate in this pilot, device sponsors:
For the joint eSTAR pilot, Health Canada will not be accepting regulatory enrollment process (REP) submissions.
At this time, the FDA and Health Canada are only accepting eSTAR submissions in English. eSTAR submissions in French will follow at a later time for submissions to Health Canada only.
To request participation in the pilot, send an email to both meddevices-instrumentsmed@hc-sc.gc.ca and eSubPilot@fda.hhs.gov with the subject line “Request for participation in eSTAR Pilot”.
Include the following information in your email:
The FDA and Health Canada intend to respond to your request for participation within the eSTAR pilot within 3 business days.
If you are accepted into the eSTAR pilot, the FDA and Health Canada will provide you with an information package that includes:
Please note the following constraints regarding the size and count of attachments added to eSTAR.
Revise your original eSTAR and indicate in the "Application/Submission Type" section of the eSTAR that the Application Sub-Type is a response to a request for additional information.
After you indicate the intent to provide a response to a request for additional information from the FDA, an additional section will appear near the end of the eSTAR. In this section, you can provide responses to requests for additional information.
Responses to additional information requests are not within the scope of this pilot and should be submitted as per the instructions on the request from Health Canada.
eSTAR submissions are subject to user fees.
Health Canada user fees:
The review timelines will remain the same as they are for non-pilot submissions.
For malfunctions or errors in the eSTAR, please email: eSubPilot@fda.hhs.gov.
For regulatory process or content questions, please email: